Literature DB >> 24568964

Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.

Min-Jung Kwon1, Kyoung Ho Roh2, Hyosoon Park1, Hee-Yeon Woo3.   

Abstract

BACKGROUND: Human papillomavirus (HPV) testing is an important part of cervical cancer screening and management of women with abnormal cytology results. The Hybrid Capture 2 (HC2) has been recommended for use as a reference test.
OBJECTIVE: To evaluate a new real-time PCR assay (Anyplex II HPV28) for detecting high risk (HR) HPV and to compare it to the HC2. In addition, we compared the genotyping results of the Anyplex II HPV28 to those of sequencing analysis. STUDY
DESIGN: A total of 1114 cervical swab specimens were consecutively obtained from a single healthcare center. We submitted all specimens for HPV detection with Anyplex II HPV28 and HC2, then analyzed the discordant results using multiplex PCR followed by direct sequencing.
RESULTS: HC2 detected 72 (6.5%) cases with HR HPV, while Anyplex II HPV28 identified 138 (12.4%) cases. The overall agreement rate was 91.4% (1018/1114) of cases. Discordant results between these two assays were observed in 96 cases; 15 were positive only by HC2, and 81 were positive only by Anyplex II HPV28. Sequencing analyses performed in 80 cases of discordant results revealed 11 false-positive, and 67 false-negative results using HC2 tests and two false-positive results using Anyplex II HPV28.
CONCLUSIONS: The Anyplex II HPV28 assay is analytically more sensitive in the detection of the 13 HR types represented by the HC2 assay and exhibited a higher concordance with comprehensive genotyping based on the sequencing analysis, and it could be used as a laboratory testing method for identifying HPV genotypes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anyplex II HPV28; Genotypes; HC2; Human papilloma virus

Mesh:

Year:  2014        PMID: 24568964     DOI: 10.1016/j.jcv.2014.01.015

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  18 in total

1.  Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

Authors:  A M Cornall; M Poljak; S M Garland; S Phillips; J H Tan; D A Machalek; M A Quinn; S N Tabrizi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-08       Impact factor: 3.267

2.  Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping.

Authors:  Yong Kwan Lim; Jee-Hye Choi; Serah Park; Oh Joo Kweon; Ae Ja Park
Journal:  J Clin Lab Anal       Date:  2016-04-28       Impact factor: 2.352

3.  Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.

Authors:  Gulixian Tuerxun; Awaguli Yukesaier; Ling Lu; Kailibinuer Aierken; Patiman Mijiti; Yujie Jiang; Axianguli Abulizi; Yuanyuan Zhang; Guzhanuer Abuduxikuer; Guzhalinuer Abulizi; Hua Li
Journal:  Oncologist       Date:  2016-06-17

4.  Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

Authors:  Anja Oštrbenk; Lan Xu; Marc Arbyn; Mario Poljak
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

5.  Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea.

Authors:  Kyeong A So; Jin Hwa Hong; Jae Kwan Lee
Journal:  J Cancer Prev       Date:  2016-06-30

6.  Use of swabs for dry collection of self-samples to detect human papillomavirus among Malagasy women.

Authors:  Pierre Vassilakos; Rosa Catarino; Stephanie Bougel; Maria Munoz; Caroline Benski; Ulrike Meyer-Hamme; Jeromine Jinoro; Josea Lea Heriniainasolo; Patrick Petignat
Journal:  Infect Agent Cancer       Date:  2016-03-17       Impact factor: 2.965

7.  No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population.

Authors:  Jeong Eun Lee; Yong-Moon Lee; In-Ock Seong; Min-Woong Kang; Choong Sik Lee; Kyung-Hee Kim
Journal:  Osong Public Health Res Perspect       Date:  2016-10-21

8.  Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.

Authors:  Yung Taek Ouh; Kyung Jin Min; Hyun Woong Cho; Moran Ki; Jin Kyoung Oh; Sang Yop Shin; Jin Hwa Hong; Jae Kwan Lee
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

9.  Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea.

Authors:  Taekmin Kwon; Kyung Hyun Moon; Sung-Hak Yang; Min Cheol Roh; Sang Hoon Lee; Je Won Kim; In Kyu Kim; Kyoung Ho Roh; Sungchan Park
Journal:  J Korean Med Sci       Date:  2016-02-04       Impact factor: 2.153

10.  Randomized Comparison of Two Vaginal Self-Sampling Methods for Human Papillomavirus Detection: Dry Swab versus FTA Cartridge.

Authors:  Rosa Catarino; Pierre Vassilakos; Aline Bilancioni; Mathieu Vanden Eynde; Ulrike Meyer-Hamme; Pierre-Alain Menoud; Frédéric Guerry; Patrick Petignat
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.